Cash flow The New York Times Company

Equities

NYT

US6501111073

Consumer Publishing

Market Closed - Nyse Other stock markets 04:00:02 2026-03-13 pm EDT			5-day change	1st Jan Change
79.31 ^USD	+1.60%		-1.40%	+14.25%

Mar. 06	Judge skeptical of Pentagon's restrictions on press access	RE
Mar. 05	New York Times Insider Sold Shares Worth $1,034,280, According to a Recent SEC Filing	MT

40ab8adf24a738cc76ed60c576.uXo2GOqUOCvQgtLH-P5hd0U4h_KdN6iIA2NLrBSsmmM.6D54fq7BfEmE4eekqp0vBHZ74ofQdeT5ewl8_0bJ0AbJK3p8rN1qH77Smw

Published financial data: THE NEW YORK TIMES COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.86B	2.08B	2.16B	2.29B	2.52B
Other Revenues, Total	188M	204M	238M	264M	281M
Total Revenues	2.05B	2.28B	2.4B	2.56B	2.8B
Cost of Goods Sold, Total	1.04B	1.21B	1.25B	1.31B	1.39B
Gross Profit	1.01B	1.07B	1.15B	1.25B	1.41B
Selling General & Admin Expenses, Total	555M	558M	558M	583M	645M
R&D Expenses	161M	204M	229M	248M	264M
Depreciation & Amortization - (IS)	57.5M	82.65M	86.12M	82.94M	85.01M
Other Operating Expenses	-27M	-29M	-27M	-27M	-27M
Other Operating Expenses, Total	746M	816M	846M	888M	968M
Operating Income	262M	254M	304M	362M	440M
Interest Expense, Total	-769K	-797K	-1.01M	-1.02M	-1.17M
Interest And Investment Income	6.56M	7.26M	22.12M	37.5M	43.48M
Net Interest Expenses	5.79M	6.46M	21.1M	36.48M	42.31M
Income (Loss) On Equity Invest.	-	-	2.48M	-	-
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	268M	261M	328M	398M	483M
Restructuring Charges	-882K	-4.67M	-7.58M	-7.51M	-9.45M
Merger & Related Restructuring Charges	-	-34.71M	-	-	-
Gain (Loss) On Sale Of Investments	27.16M	-	-	-	-4.06M
Gain (Loss) On Sale Of Assets	-	34.23M	-	-	-
Asset Writedown	-	-4.07M	-15.24M	-	-2.86M
Legal Settlements	-	-	-	-10.8M	-13.32M
Other Unusual Items	-3.71M	-15.45M	-2.51M	3.35M	-1.79M
EBT, Incl. Unusual Items	291M	236M	303M	383M	451M
Income Tax Expense	70.53M	62.09M	69.84M	89.6M	107M
Earnings From Continuing Operations	220M	174M	233M	294M	344M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	220M	174M	233M	294M	344M
Minority Interest	-	-	-365K	-	-
Net Income - (IS)	220M	174M	232M	294M	344M
Net Income to Common Incl Extra Items	220M	174M	232M	294M	344M
Net Income to Common Excl. Extra Items	220M	174M	232M	294M	344M
Per Share Items
Net EPS - Basic	1.31	1.04	1.41	1.79	2.11
Basic EPS - Continuing Operations	1.31	1.04	1.41	1.79	2.11
Basic Weighted Average Shares Outstanding	168M	167M	165M	164M	163M
Net EPS - Diluted	1.31	1.04	1.4	1.77	2.09
Diluted EPS - Continuing Operations	1.31	1.04	1.4	1.77	2.09
Diluted Weighted Average Shares Outstanding	169M	167M	166M	166M	165M
Normalized Basic EPS	1	0.98	1.24	1.51	1.85
Normalized Diluted EPS	0.99	0.97	1.23	1.5	1.83
Dividend Per Share	0.28	0.36	0.44	0.52	0.72
Payout Ratio	20.61	32.66	29.89	28.2	32.08
Supplemental Items
EBITDA	311M	329M	383M	438M	518M
EBITA	262M	281M	334M	389M	468M
EBIT	262M	254M	304M	362M	440M
EBITDAR	324M	344M	396M	452M	532M
Total Revenues (As Reported)	2.07B	2.31B	2.43B	2.59B	2.82B
Effective Tax Rate - (Ratio)	24.28	26.31	23.08	23.37	23.77
Current Domestic Taxes	75.85M	106M	87.04M	79.3M	66.07M
Current Foreign Taxes	1.04M	1.9M	2.59M	2.36M	2.68M
Total Current Taxes	76.89M	108M	89.63M	81.66M	68.75M
Deferred Domestic Taxes	-6.36M	-46.15M	-19.79M	7.94M	38.81M
Deferred Foreign Taxes	-	-	-	-	-280K
Total Deferred Taxes	-6.36M	-46.15M	-19.79M	7.94M	38.53M
Normalized Net Income	167M	163M	205M	249M	302M
Interest Capitalized	11K	3K	-	-	-
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	9.6M	3M	-6.18M	2.37M	17.71M
Supplemental Operating Expense Items
Marketing Expenses	200M	151M	138M	152M	164M
Selling and Marketing Expenses	295M	268M	260M	278M	307M
General and Administrative Expenses	249M	284M	300M	301M	320M
Research And Development Expense From Footnotes	161M	204M	229M	248M	264M
Net Rental Expense, Total	13.5M	15.27M	13.67M	13.7M	14.43M
Imputed Operating Lease Interest Expense	1.25M	1.38M	1.82M	2.21M	2.79M
Imputed Operating Lease Depreciation	12.25M	13.89M	11.85M	11.49M	11.64M
Stock-Based Comp., COGS (Total)	5.22M	8.03M	12.8M	16.83M	16.53M
Stock-Based Comp., R&D Exp. (Total)	3.66M	10.88M	20.19M	25.95M	26.78M
Stock-Based Comp., S&M Exp. (Total)	1.28M	1.24M	1.6M	1.6M	3.06M
Stock-Based Comp., G&A Exp. (Total)	12.06M	15.16M	20.18M	23.12M	27.82M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	22.22M	35.31M	54.78M	67.5M	74.18M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	320M	221M	289M	199M	255M
Short Term Investments	341M	126M	162M	366M	387M
Total Cash And Short Term Investments	661M	347M	452M	566M	642M
Accounts Receivable, Total	233M	218M	242M	250M	291M
Total Receivables	233M	218M	242M	250M	291M
Prepaid Expenses	33.2M	54.86M	59.71M	49.87M	60.02M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	25.55M	35.93M	27.89M	71M	35.07M
Total Current Assets	953M	656M	782M	936M	1.03B
Gross Property Plant And Equipment	1.42B	1.43B	1.42B	1.43B	1.44B
Accumulated Depreciation	-778M	-823M	-870M	-906M	-945M
Net Property Plant And Equipment	638M	611M	550M	521M	496M
Long-term Investments	441M	169M	287M	375M	550M
Goodwill	166M	414M	416M	412M	409M
Other Intangibles, Total	14.2M	317M	285M	258M	229M
Accounts Receivable Long-Term	-	36M	-	-	-
Deferred Tax Assets Long-Term	95.8M	96.36M	115M	111M	72.83M
Other Long-Term Assets, Total	256M	234M	280M	227M	211M
Total Assets	2.56B	2.53B	2.71B	2.84B	3B
Liabilities
Accounts Payable, Total	127M	115M	117M	124M	136M
Accrued Expenses, Total	296M	288M	312M	291M	310M
Current Portion of Leases	9.08M	9.91M	10.08M	10.52M	12.12M
Unearned Revenue Current, Total	119M	156M	173M	187M	208M
Other Current Liabilities	7.5M	2.52M	-	1.6M	1.61M
Total Current Liabilities	559M	571M	612M	614M	667M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	63.61M	59.12M	42.9M	37.26M	36.6M
Pension & Other Post Retirement Benefits	331M	252M	239M	215M	211M
Other Non Current Liabilities	69.43M	51.69M	58.06M	48.84M	41.6M
Total Liabilities	1.02B	934M	951M	914M	956M
Common Stock, Total	17.68M	17.71M	17.78M	17.87M	17.98M
Additional Paid In Capital	230M	256M	301M	356M	412M
Retained Earnings	1.85B	1.96B	2.12B	2.33B	2.55B
Treasury Stock	-171M	-276M	-321M	-406M	-573M
Comprehensive Income and Other	-383M	-358M	-353M	-366M	-366M
Total Common Equity	1.54B	1.6B	1.76B	1.93B	2.04B
Minority Interest	2M	2M	-	-	-
Total Equity	1.54B	1.6B	1.76B	1.93B	2.04B
Total Liabilities And Equity	2.56B	2.53B	2.71B	2.84B	3B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	168M	164M	164M	163M	161M
ECS Total Common Shares Outstanding	168M	165M	165M	164M	162M
Book Value / Share	9.17	9.68	10.72	11.77	12.61
Tangible Book Value	1.36B	867M	1.06B	1.26B	1.4B
Tangible Book Value Per Share	8.09	5.25	6.45	7.68	8.67
Total Debt	72.69M	69.04M	52.99M	47.78M	48.72M
Net Debt	-1B	-417M	-656M	-864M	-1.12B
Debt Equivalent of Unfunded Proj. Benefit Obligation	165M	110M	97.54M	95.48M	90.16M
Debt Equivalent Oper. Leases	108M	122M	109M	110M	115M
Minority Interest, Total (Incl. Fin. Div)	2M	2M	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	106M	106M	107M	107M	107M
Buildings, Total	724M	730M	730M	737M	745M
Machinery, Total	427M	442M	447M	452M	467M
Full Time Employees	5K	5.8K	5.9K	5.9K	6K
Accumulated Allowance for Doubtful Accounts (Supple)	12.37M	12.26M	12.8M	12.12M	11.41M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	220M	174M	232M	294M	344M
Depreciation & Amortization - CF	57.89M	57.58M	58.25M	57.52M	60.05M
Amortization of Goodwill and Intangible Assets - (CF)	-	27.1M	29.3M	27.5M	27.6M
Depreciation & Amortization, Total	57.89M	84.68M	87.55M	85.02M	87.65M
Amortization of Deferred Charges, Total - (CF)	9.1M	7.9M	7.8M	7M	7.5M
(Gain) Loss From Sale Of Asset	-	-34.23M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-27.16M	-	-	-	-
Asset Writedown & Restructuring Costs	-	4.07M	15.24M	-	2.86M
(Income) Loss On Equity Investments - (CF)	-	-	-2.48M	-	-
Stock-Based Compensation (CF)	22.22M	35.31M	54.78M	67.5M	74.18M
Other Operating Activities, Total	-18.42M	-15.98M	-27.48M	-37.4M	-6.64M
Change In Accounts Receivable	-49.22M	20.89M	-24.96M	-7.04M	-41.29M
Change In Accounts Payable	46.05M	-111M	-7.32M	-21.03M	55.65M
Change in Unearned Revenues	13.95M	8.59M	16.83M	14.31M	20.54M
Change in Other Net Operating Assets	-5.29M	-23.22M	8.28M	8.33M	40.06M
Cash from Operations	269M	151M	361M	411M	584M
Capital Expenditure	-34.64M	-36.96M	-22.67M	-29.17M	-33.98M
Cash Acquisitions	-	-516M	-	-	-
Investment in Marketable and Equity Securities, Total	-150M	477M	-142M	-289M	-200M
Other Investing Activities, Total	3.72M	2.48M	4.75M	12.51M	12.82M
Cash from Investing	-181M	-73.56M	-160M	-306M	-221M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	2.45M	3K	-	-	-
Repurchase of Common Stock	-11.2M	-115M	-59.44M	-107M	-195M
Common Dividends Paid	-45.34M	-56.79M	-69.46M	-82.86M	-110M
Common & Preferred Stock Dividends Paid	-45.34M	-56.79M	-69.46M	-82.86M	-110M
Other Financing Activities, Total	-862K	-2.59M	-3.8M	-3.02M	-431K
Cash from Financing	-54.95M	-174M	-133M	-193M	-306M
Foreign Exchange Rate Adjustments	-1M	-1.95M	-219K	-1.03M	-430K
Net Change in Cash	32.34M	-99.13M	68M	-89.32M	56.6M
Supplemental Items
Cash Interest Paid	546K	1.58M	708K	716K	111K
Cash Income Tax Paid (Refund)	66.44M	110M	71.81M	113M	71.95M
Levered Free Cash Flow	239M	244M	335M	317M	446M
Unlevered Free Cash Flow	240M	244M	336M	318M	447M
Change In Net Working Capital	-21.4M	5.43M	-18.41M	38.78M	-36.05M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.73	6.23	7.25	8.14	9.43
Return on Total Capital	10.91	9.68	10.92	11.93	13.54
Return On Equity %	15.34	11.07	13.84	15.92	17.34
Return on Common Equity	15.36	11.09	13.83	15.92	17.34
Margin Analysis
Gross Profit Margin %	49.24	46.96	47.94	48.83	50.33
SG&A Margin	27.09	24.5	23.25	22.8	23.07
EBITDA Margin %	15.16	14.43	15.95	17.11	18.51
EBITA Margin %	12.8	12.34	13.91	15.22	16.73
EBIT Margin %	12.8	11.15	12.69	14.14	15.74
Income From Continuing Operations Margin %	10.74	7.63	9.7	11.48	12.29
Net Income Margin %	10.74	7.63	9.69	11.48	12.29
Net Avail. For Common Margin %	10.74	7.63	9.69	11.48	12.29
Normalized Net Income Margin	8.18	7.15	8.53	9.73	10.78
Levered Free Cash Flow Margin	11.69	10.7	13.98	12.39	15.94
Unlevered Free Cash Flow Margin	11.71	10.72	14.01	12.42	15.96
Asset Turnover
Asset Turnover	0.84	0.89	0.91	0.92	0.96
Fixed Assets Turnover	3.19	3.65	4.13	4.78	5.5
Receivables Turnover (Average Receivables)	8.93	9.22	9.4	9.33	9.32
Short Term Liquidity
Current Ratio	1.7	1.15	1.28	1.53	1.54
Quick Ratio	1.6	0.99	1.13	1.33	1.4
Operating Cash Flow to Current Liabilities	0.48	0.26	0.59	0.67	0.88
Days Sales Outstanding (Average Receivables)	40.77	40.15	38.84	39.24	39.18
Average Days Payable Outstanding	43.81	36.99	33.84	33.62	34.04
Long Term Solvency
Total Debt/Equity	4.72	4.31	3	2.48	2.39
Total Debt / Total Capital	4.51	4.14	2.92	2.42	2.33
LT Debt/Equity	4.13	3.7	2.43	1.93	1.79
Long-Term Debt / Total Capital	3.94	3.54	2.36	1.89	1.75
Total Liabilities / Total Assets	39.91	36.85	35.05	32.18	31.89
EBIT / Interest Expense	340.9	318.95	300.14	355.85	377.4
EBITDA / Interest Expense	421.4	431.9	390.85	444	456.18
(EBITDA - Capex) / Interest Expense	376.35	385.53	368.5	415.31	427.06
Total Debt / EBITDA	0.22	0.2	0.13	0.11	0.09
Net Debt / EBITDA	-3.09	-1.21	-1.66	-1.91	-2.1
Total Debt / (EBITDA - Capex)	0.25	0.22	0.14	0.11	0.1
Net Debt / (EBITDA - Capex)	-3.46	-1.36	-1.76	-2.05	-2.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.71	11.3	5.26	6.66	9.34
Gross Profit, 1 Yr. Growth %	26.78	6.16	7.45	8.64	12.71
EBITDA, 1 Yr. Growth %	39.98	5.93	16.32	14.42	18.29
EBITA, 1 Yr. Growth %	50.3	7.31	18.6	16.71	20.19
EBIT, 1 Yr. Growth %	50.3	-3.03	19.72	18.91	21.7
Earnings From Cont. Operations, 1 Yr. Growth %	118.15	-20.94	33.84	26.24	17.07
Net Income, 1 Yr. Growth %	119.74	-20.94	33.63	26.44	17.07
Normalized Net Income, 1 Yr. Growth %	39.92	-2.71	25.57	21.71	21.17
Diluted EPS Before Extra, 1 Yr. Growth %	118.49	-20.6	34.62	26.43	18.08
Accounts Receivable, 1 Yr. Growth %	26.79	-6.6	11.47	2.9	16.55
Net Property, Plant and Equip., 1 Yr. Growth %	-1.44	-4.11	-10.09	-5.18	-4.86
Total Assets, 1 Yr. Growth %	11.11	-1.18	7.14	4.67	5.48
Tangible Book Value, 1 Yr. Growth %	17.71	-36.19	22.5	18.41	11.59
Common Equity, 1 Yr. Growth %	16.08	3.85	10.34	9.3	5.92
Cash From Operations, 1 Yr. Growth %	-9.68	-44	139.32	13.84	42.38
Capital Expenditures, 1 Yr. Growth %	0.54	6.71	-38.67	28.69	16.49
Levered Free Cash Flow, 1 Yr. Growth %	-4.67	1.9	37.55	-5.46	40.62
Unlevered Free Cash Flow, 1 Yr. Growth %	-4.66	1.9	37.53	-5.45	40.57
Dividend Per Share, 1 Yr. Growth %	16.67	28.57	22.22	18.18	38.46
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.23	13.97	8.24	5.96	7.99
Gross Profit, 2 Yr. CAGR %	12.76	16.01	6.8	8.04	10.65
EBITDA, 2 Yr. CAGR %	19.39	21.79	10.98	15.44	16.81
EBITA, 2 Yr. CAGR %	22.67	27.02	12.78	17.74	18.99
EBIT, 2 Yr. CAGR %	22.67	20.75	7.72	19.42	20.91
Earnings From Cont. Operations, 2 Yr. CAGR %	25.36	31.32	2.86	29.98	21.57
Net Income, 2 Yr. CAGR %	25.36	31.81	2.78	29.98	21.66
Normalized Net Income, 2 Yr. CAGR %	26.09	16.69	10.5	23.73	22.02
Diluted EPS Before Extra, 2 Yr. CAGR %	25.63	31.71	3.38	30.46	22.18
Accounts Receivable, 2 Yr. CAGR %	3.65	8.82	2.04	7.1	9.51
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.22	-2.78	-7.15	-7.67	-5.02
Total Assets, 2 Yr. CAGR %	10.79	4.78	2.89	5.9	5.07
Tangible Book Value, 2 Yr. CAGR %	14.65	-13.34	-11.59	20.44	14.95
Common Equity, 2 Yr. CAGR %	14.58	9.8	7.05	9.82	7.6
Cash From Operations, 2 Yr. CAGR %	19.04	-28.88	15.76	65.05	27.31
Capital Expenditures, 2 Yr. CAGR %	-12.69	3.58	-19.1	-11.16	22.44
Levered Free Cash Flow, 2 Yr. CAGR %	33.47	-1.43	18.37	14.1	15.63
Unlevered Free Cash Flow, 2 Yr. CAGR %	25.97	-1.42	18.36	14.09	15.62
Dividend Per Share, 2 Yr. CAGR %	18.32	22.47	25.36	20.18	27.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.87	8.57	10.99	7.71	7.07
Gross Profit, 3 Yr. CAGR %	9.04	10.51	13.08	7.41	9.57
EBITDA, 3 Yr. CAGR %	10.28	14.72	19.94	12.11	16.39
EBITA, 3 Yr. CAGR %	11.67	17.32	24.15	14.08	18.55
EBIT, 3 Yr. CAGR %	11.67	13.42	20.41	11.33	20.17
Earnings From Cont. Operations, 3 Yr. CAGR %	19.95	7.51	32.16	10.13	25.53
Net Income, 3 Yr. CAGR %	20.51	7.51	32.41	10.13	25.53
Normalized Net Income, 3 Yr. CAGR %	14.26	15.65	19.58	14.12	22.87
Diluted EPS Before Extra, 3 Yr. CAGR %	20.43	7.81	32.67	10.55	26.19
Accounts Receivable, 3 Yr. CAGR %	1.16	0.11	9.7	2.32	10.16
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.07	-3.52	-5.28	-6.5	-6.74
Total Assets, 3 Yr. CAGR %	5.28	6.64	5.56	3.48	5.76
Tangible Book Value, 3 Yr. CAGR %	14.68	-5.7	-2.74	-2.55	17.41
Common Equity, 3 Yr. CAGR %	13.92	10.89	9.98	7.79	8.51
Cash From Operations, 3 Yr. CAGR %	19.65	-7.42	6.57	15.12	57.12
Capital Expenditures, 3 Yr. CAGR %	-23.54	-6.65	-13.02	-5.56	-2.76
Levered Free Cash Flow, 3 Yr. CAGR %	48.02	21.99	10.15	9.82	22.33
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.02	17.37	10.15	9.82	22.31
Dividend Per Share, 3 Yr. CAGR %	20.51	21.64	22.39	22.92	25.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.89	6.56	6.81	7.52	9.78
Gross Profit, 5 Yr. CAGR %	1.9	0.43	8.14	9.52	12.1
EBITDA, 5 Yr. CAGR %	7.78	4.78	10.57	14.98	18.49
EBITA, 5 Yr. CAGR %	9.93	5.88	12.13	17.45	21.84
EBIT, 5 Yr. CAGR %	9.93	3.76	10.08	15.74	20.36
Earnings From Cont. Operations, 5 Yr. CAGR %	53.15	88.7	12.8	15.99	27.82
Net Income, 5 Yr. CAGR %	49.9	109.63	13.08	15.99	28
Normalized Net Income, 5 Yr. CAGR %	21.65	4.8	12.76	18.78	20.32
Diluted EPS Before Extra, 5 Yr. CAGR %	47.13	104.34	13.3	16.35	28.37
Accounts Receivable, 5 Yr. CAGR %	3.37	3.31	1.51	2.85	9.62
Net Property, Plant and Equip., 5 Yr. CAGR %	1.33	-0.94	-2.96	-5.2	-5.18
Total Assets, 5 Yr. CAGR %	3.25	3.83	4.32	6.34	5.37
Tangible Book Value, 5 Yr. CAGR %	13.75	2.83	3.35	4	3.98
Common Equity, 5 Yr. CAGR %	12.66	12.23	11.12	10.46	9.02
Cash From Operations, 5 Yr. CAGR %	20.97	11.69	18.08	16.67	14.43
Capital Expenditures, 5 Yr. CAGR %	2.85	-15.29	-21.79	-8.48	-0.27
Levered Free Cash Flow, 5 Yr. CAGR %	10.48	17.22	35.37	18.74	12.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.77	13.68	29.24	16.02	12.18
Dividend Per Share, 5 Yr. CAGR %	11.84	17.61	22.42	21.06	24.57